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ABSTRACT 
 
    Purpose: The feasibility of automatic event driven electrical stimulation of the dorsal 
penile/clitoral nerve in treatment of neurogenic detrusor overactivity (NDO) was evaluated in 
individuals with spinal cord injury (SCI). 
    Materials and Methods: The study included 2 women and 14 men with NDO, bladder capacities 
below 500 ml, age over 18 years and complete or incomplete suprasacral SCI. Detrusor pressure 
(Pdet) was recorded during an ordinary natural bladder filling. In a similar subsequent recording Pdet 
was used to trigger electrical stimulation when the pressure exceeded 10 cmH2O. 
    Results: Of the 16 patients enrolled in this study 13 had an increased bladder capacity together 
with a storage pressure decrease as a result of automatic event driven electrical stimulation. In two 
patients the stimulation could not inhibit the first undesired contraction and leakage occurred and 
finally one patient could not tolerate the stimulation. During the stimulated filling Pdet never 
exceeded 55 cmH2O and the storage pressure is thus sufficiently low to prevent kidney damage. An 
average bladder capacity increase of 53% was obtained.  
    Conclusions: This study demonstrates the feasibility of automatic event driven electrical 
stimulation in the treatment of NDO. Although the setup in this experiment is not suitable in a 
clinical setting, the treatment modality is promising and it warrants further investigation.   
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Introduction 
Neurogenic bladder dysfunction after spinal cord injury (SCI) is a major medical and social 
problem for which there is no ideal treatment. After suprasacral SCI cortical control over the sacral 
reflex voiding center is impaired and in the majority of patients neurogenic detrusor overactivity 
(NDO) and/or detrusor-sphincter dyssynergia (DSD) emerges [1,2]. Detrusor overactivity is a 
urodynamic observation characterized by involuntary detrusor contractions during the filling phase, 
which may be spontaneous or provoked, while DSD is defined as a detrusor contraction concurrent 
with involuntary contraction of the urethral and/or periurethral striated muscle [3]. Patients with 
SCI who have NDO and/or DSD often have transient high intravesical pressures, low bladder 
capacity and incontinence. Recurrent urinary tract infections and vesicoureteral reflux may lead to 
upper tract damage. Therefore, the primary goal of NDO management is to reestablish low pressure 
storage and prevent recurrent bladder infections to preserve renal function. A secondary goal is to 
increase storage capacity. 
First line treatment for NDO is the oral administration of anticholinergic drugs, such as oxybutynin 
and tolterodine. This treatment is often combined with clean intermittent self-catheterization to 
empty the bladder and decrease residual urine. However, many patients are refractory to the 
medication or have dose limiting side effects. Alternative therapies are used when conservative 
methods fail. These therapies include the oral administration of -adrenoceptor antagonists [4], 
intravesical installation of capsaicin or resiniferatoxin [5], injection of botulinum toxin in the 
detrusor muscle [6], bladder augmentation cystoplasty [7] and detrusor deafferentation [8]. An 
option that does not require ablative and irreversible surgery is electrical stimulation. This approach 
depends on a physiological process known as neuromodulation, in which activity in 1 neural 
pathway modulates activity in another through synaptic interaction [9]. It has been shown that 
electrical stimulation of pudendal nerve afferents can inhibit bladder contractions in patients with 
SCI and bladder capacity can be increased by continuous [10] as well as conditional stimulation 
[11, 12]. 
Implants such as the InterStim® system have made this treatment modality commercially available. 
Common to these implantable systems is that they use continuous stimulation. Detrusor inhibition is 
in principal only necessary during an involuntary contraction and, thus, stimulation could be turned 
off between contractions. Such a stimulation scheme could have a number of advantages. Power 
consumption may be decreased and, thus, extend battery lifetime. Furthermore, continuous 
stimulation of a reflex may lead to habituation, which would be minimized or prevented by 
conditional stimulation. In this study we examined the effect of the automatic, event driven 
electrical stimulation of pudendal nerve afferents on bladder capacity in patients with SCI. 
Materials and Methods 
Methods, definitions and units conform to the standards recommended by the International 
Continence Society except where specifically noted. The study was approved by the local ethics 
committee and informed consent was obtained from all patients. A total of 16 patients with SCI 
were included (table 1). Inclusion criteria were NDO with bladder capacity less than 500 ml, age 
greater than 18 years and complete or incomplete suprasacral SCI. Participants were not asked to 
change bladder management prior to participating in this study, for example medication use. 
Stimulation was performed with a custom-made, battery driven stimulator using pairs of round, 
self-adhesive, platinum PALS® surface electrodes 3.2 cm in diameter placed on the base of the 
penis or on the clitoris. The parameters were 20 pulses per second and pulse width 200 seconds. 
Stimulation amplitude was gradually increased until the bulbocavernosus reflex (BCR) was elicited. 
This was determined by observation or palpation of an anal sphincter contraction. During event 
driven stimulation an amplitude of 2  BCR was used. This amplitude was chosen based on the 
study of Previnaire et al. [14]. They reported the relationship between detrusor inhibition and 
current amplitude when stimulating the dorsal penile/clitoral nerve via surface electrodes. Other 
studies evaluating conditional stimulation also used the same amplitude [11, 12]. Natural bladder 
filling was used to avoid artifacts caused by artificial high filling rates and patients were encouraged 
to drink. Vesical pressure (Pves) and abdominal pressure (Pabd) were measured using an 8Fr water 
filled catheter and a 9Fr water filled rectal balloon catheter, respectively. The catheters were 
connected via external pressure transducers to a custom-made portable device [15]. Electrical 
stimulation was automatically applied based on calculated detrusor pressure (Pdet) (fig. 1). Each 
patient underwent 2 filling sessions, that is 1) control filling and 2) filling with stimulation enabled. 
Stimulation was applied when Pdet exceeded 10 cmH2O. It was stopped in certain cases, namely 1) 
automatically when Pdet remained below 10 cmH2O for 10 seconds, 2) manually when leakage was 
detected by visual inspection and 3) manually when stimulation time exceeded 2 minutes without a 
decrease in pressure. Additional control filling was performed in 7 patients. To evaluate the effect 
of penile/clitoral nerve stimulation 4 parameters were calculated/extracted per subject, including 1) 
average Pdet peak pressure during contractions in control filling, 2) average Pdet peak pressure during 
suppressed contractions in stimulated filling, 3) bladder volume at first contraction during 
stimulated filling, calculated on the assumption of constant urine production during bladder filling, 
and 4) bladder volume at the time of leakage in stimulated filling, measured as the volume leaked 
plus residual urine at the end of bladder filling (fig. 2). 
 
Table 1. Patient characteristics 
No. men/women 14/2 
Time since SCI 3 months – 36 years 
SCI Level C4/5 - L4/5 
No. SCI Completeness:*  
Complete 8 
Incomplete 6 
No. Main bladder emptying 
method: 
 
Clean intermittent self-
catheterization 
13 
Diaper 2 
Suprapubic tapping 1 
No. bladder management 
medication 
11 
*Completeness was classified according to the ASIA 
protocol
13
                                          
 
A change in peak storage pressure and a change in bladder capacity as a result of stimulation were 
calculated as the ratios, average Pdet peak pressure during suppressed contractions in stimulated 
filling/average Pdet peak pressure during contractions in control filling and 1 – bladder volume at 
first contraction during stimulated filling/bladder volume at the time of leakage in stimulated filling, 
respectively. To evaluate the efficacy of stimulation a certain success criterion was used, that is a 
good responder is a patient in whom electrical stimulation inhibited at least the first unstable 
detrusor contraction, thereby, preserving continence. The capacity increase was calculated based on 
the assumption that, had the patient not undergone stimulation, the first uninhibited detrusor 
contraction would have led to leakage. Consequently the time from the first inhibited contraction 
until leakage was regarded as the increase in filling time. Under the assumption of constant urine 
production during the time of stimulated filling the relative increase in filling time equaled the 
relative increase in capacity. The order of control and stimulated filling was not randomized since 
the bladder exceeds normal capacity during stimulated filling. Increased bladder wall stretch would 
more likely bias a subsequent control filling than the opposite order of fillings. 
 
 Results 
Penile/clitoral nerve stimulation was well tolerated in 15 of the 16 patients. Of these 15 patients 13 
fulfilled the success criterion of having at least 1 inhibited detrusor contraction. One patient had 
leakage, although stimulation decreased peak storage pressure by 65% compared with control 
filling, and 1 did not respond to stimulation. The 3 patients who did not meet the success criterion 
were excluded from the calculation of average values (table 2). Figure 2 shows recorded data on 1 
patient. In control filling NDO occurred after 25 minutes of natural bladder filling, causing 
transient, high intravesical pressure with a peak of 89 cmH2O. Leakage (100 ml) occurred at this 
time with a subsequent residual volume of 90 ml. In stimulated filling NDO occurred after 54 
minutes. Estimated bladder volume at this time was 348 ml (fig. 2). Stimulation with 60 mA was 
automatically applied as Pdet exceeded the 10 cmH2O threshold and the effect of stimulation was a 
sudden decrease in pressure. Pdet decreased to below the threshold 8 seconds after the onset of 
stimulation and it remained there more than 10 seconds, causing stimulation to stop automatically. 
During the next 21 minutes an additional 9 detrusor contractions occurred and the sequence of 
events described was repeated at each contraction. Eventually stimulation was unable to keep 
detrusor pressure below the threshold. After 2 minutes with constant high pressure stimulation was 
stopped manually. The result was an immediate leakage of 130 ml with a subsequent residual 
volume of 357 ml (fig. 2). Average peak storage pressure during the stimulation time was 28 
cmH2O (fig. 2). Automatic, event driven stimulation in this patient resulted in a peak storage 
pressure decrease of 69%, concurrent with an extended filling time of 21 minutes. The later was 
equivalent to a relative increase in filling time of 40% and, therefore, also equivalent to a bladder 
capacity increase of 40%. Table 2 lists summarized data on all patients. Figure 3 shows individual 
as well as overall average peak storage pressures during contractions in control and stimulated 
fillings. Figure 4 shows individual as well as overall average bladder volumes at the time of the first 
contraction and at the time of leakage. 
 
FIG. 1. Experimental setup for recording Pves and Pabd with automatic, pressure activated stimulation control. Recording 
unit can be connected to personal computer for online monitoring of pressure lines and for setting threshold (Th). 
  
 
Several patients with incomplete injuries reported that the sensation of electrical stimulation was 
different when received during a detrusor contraction compared with when the necessary 
stimulation intensity was initially examined. No patient experienced 2  BCR intensity as being 
painful. However, 4 patients described stimulation as being slightly unpleasant. Interestingly the 
same patients reported that, while being stimulated during a detrusor contraction, the sensation of 
urge disappeared and they preferred the stimulation over the urge. An additional control filling was 
performed in 7 patients in our study. No apparent carryover effect of stimulation was observed since 
the prestimulated control was similar to the poststimulated control. 
  
 
 
FIG. 2. Two fillings in 1 patient, recorded consecutively. Stimulation was turned on automatically when Pdet exceeded 
10 cmH2O and it had clear inhibitory effect on detrusor contraction. Stimulation was turned off automatically when 
Pdet had remained under threshold for 10 seconds. At end of stimulated filling stimulation had been on more than 2 
minutes without decrease in pressure and, thus, it was manually disabled. Result was immediate leakage (L). A, average 
Pdet peak during control filling contractions. B, average Pdet peak during stimulated filling suppressed contractions. C, 
bladder volume at stimulated filling first contraction. D, bladder volume at stimulated filling leakage. 
FIGURE 3: Average peak of Pdet during contractions in the 
control filling (A) and during suppressed contractions in 
the stimulated filling (B). Circles indicate individual 
values, boxes are mean values and T-bars are standard 
deviation. 
FIGURE 4: Bladder volume at 1st contraction (C) and at 
leakage (D) in the stimulated filling. Circles indicate 
individual values, boxes are mean values and T-bars are 
standard deviation. 
 TABLE 2. Storage pressure, bladder capacity, filling time and 
stimulation parameters 
 Mean ± SD 
Stimulation amplitude (2  threshold to elicit BCR) (mA) 53 ± 11 
Av Pdet peak (cmH2O):  
    During control filling contractions 72 ± 28 
    During stimulated filling suppressed contractions 28 ± 13 
% Peak storage pressure decrease 58 ± 18 
Vol (ml):  
    Estimated at first contraction 321 ± 114 
    Measured at leakage 480 ± 176 
Bladder capacity increase:  
    Absolute (ml) 158 ± 89 
    % Relative 53 ± 36 
No. stimulated filling inhibited contractions 16 ± 17 
Time in stimulated filling (mins):  
    First contraction 41 ± 23 
    Leakage 62 ± 25 
% Stimulation on time/leakage time 13.6 ± 10.2 
Urine production rate (ml/min) 8.7 ± 4.2 
Values in 13 patients who fulfilled the success criteria of at least 1 inhibited 
detrusor contraction. 
 
Discussion 
This study demonstrates the feasibility of automatic, event driven electrical stimulation of the 
pudendal afferent nerves in the treatment of NDO in patients with SCI. Transient high intravesical 
pressures are decreased due to a stimulation induced detrusor inhibition, which together with 
possible reflex mediated sphincter activation also accounts for the increased bladder capacity. There 
is no consensus on the exact value at which intravesical pressure becomes dangerous to kidney 
function. However, 40 cmH2O is frequently used in the literature [16]. It is our goal to keep 
intravesical pressure below this safety level during the filling phase. Peak storage pressure in 
control filling was above the safety level in 11 of the 13 good responders. Stimulation brought peak 
storage pressure at or below the safety level in 8 of these 11 patients. Kirkham et al tested 
conditional electrical stimulation of pudendal afferent nerves with an artificial filling of 10 ml per 
minute and found an increase in bladder capacity of 144% ± 127% or 230 ± 143 ml [12]. The 
relative increase was approximately 3 times higher than our results and the absolute increase was 
about 1.5 times higher but absolute capacity was 90 ml smaller. However, a direct comparison with 
our results is difficult since their patients were asked to discontinue any medication 4 days prior to 
participating. Dalmose et al described results similar to those of Kirkham et al [12] in a study of 10 
patients with SCI, in whom conditional stimulation of pudendal afferent nerves was performed 
manually and an artificial filling rate of 60 ml per minute was used [11]. When using the calculation 
method of our study, Dalmose et al [11] noted a bladder capacity increase of 167% ± 217% or 192 
± 130 ml. The relative and absolute increases were higher but again absolute capacity was smaller 
than in our study. These high relative and absolute capacity increases in the 2 studies were mostly 
due to initial small capacity in the patients. The average patient in the study of Kirkham et al [12] 
went from a bladder capacity of approximately 160 to 390 ml and in the study of Dalmose et al [11] 
from 157 to 349 ml. This should be compared with our average patient, who went from a bladder 
capacity of 321 to 480 ml. The large initial capacity in our control was most likely due to the fact 
that the majority of patients in this study were on medication. A similar high initial capacity was 
reported by Læssøe et al when studying the effects of ejaculation by penile vibratory stimulation on 
bladder capacity in men with spinal cord lesions [17]. They found a significant increase in bladder 
capacity after 4 weeks of frequent treatment (ejaculation every third day). This method, which is 
therapeutic in nature, has also been tried with daily sessions of electrical stimulation of the 
penile/clitoral nerve but with variable success rates [18]. Mechanical and electrical stimulation may 
work through some of the same mechanisms but the relationship between short-term bladder 
inhibition and long lasting therapeutic modulation of bladder capacity is elusive. We observed no 
immediate carryover effect of electrical stimulation in the 7 patients who underwent an additional 
control filling. As mentioned, implants using continuous stimulation are commercially available. A 
5-year followup study showed a 50% decrease in the number of good responders after 3 years of 
treatment [19]. This decrease might have been due to habituation of the involved reflexes. In our 
study stimulation was on for only 13.6% of the filling phase. Thus, the possible habituation effect is 
believed to have been decreased but further studies must verify this. 
 
Conclusion 
The results of this study indicate that it is feasible to treat NDO by event driven electrical 
stimulation of the pudendal nerve. Peak storage pressure was brought down to what is believed to 
be a safe level and at the same time bladder capacity was increased. The risk of habituation was 
lowered since stimulation was only on during contractions. An extended filling time of 20 ± 13 
minutes was achieved, although patients were encouraged to drink. In ordinary life this period 
would likely be longer. With conditional stimulation patients can be warned at the time of the first 
contraction, which marks the onset of extended filling time. With a warning 20 minutes prior to 
leakage most patients would have sufficient time to find a toilet. Although the setup in this 
experiment is not suitable for the chronic setting, the treatment modality is promising. The timely 
decrease in the number of good responders among patients receiving continuous stimulation with an 
implant makes it relevant to investigate event driven stimulation. Steps are being taken to develop 
noncatheter based monitoring of bladder activity since this is needed to apply stimulation 
automatically in a chronic setting. 
 
The Danish Spinal Cord Injuries Association provided support and Morten Fjorback provided 
technical assistance. 
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